Abiopharma

Massacesi Cristian 🟢 acquired 65.3K shares (2 derivative) of BRISTOL MYERS SQUIBB CO (BMY) Transaction Date: Mar 10, 2026 | Filing ID: 000002

Director ALVAREZ CESAR L 🟢 acquired 94.5K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003682

(30% Negative) PLUS THERAPEUTICS, INC. (PSTV) Reports Q1 2026 Financial Results

📋 Mehrotra Parth (Officer) plans to sell 27K shares of Privia Health Group, Inc. (at $21.90 each, total $586K) Filed: Mar 12, 2026 | ID: 002260

Director AGEE NANCY H 🟢 acquired 92.8K shares (2 derivative) of PRECIGEN, INC. (PGEN) at $3.51 Transaction Date: Mar 10, 2026 | Filing ID: 003680

Plenge Robert M 🟡 adjusted position in 33.1K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002

Artesian Resources Corporation Reports 2025 Year-End Earnings and Fourth Quarter Results

Meyers Gregory Scott 🟡 adjusted position in 48.3K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000004

Lenkowsky Adam 🟡 adjusted position in 64.3K shares (6 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002

OKYO PHARMA LIMITED (OKYO) Files Form 6-K

(99% Neutral) PRELUDE THERAPEUTICS INCORPORATED (PRLD) Announces Business Combination

(99% Neutral) XENON PHARMACEUTICALS INC. (XENE) Announces Business Combination

(99% Neutral) LENSAR, INC. (LNSR) Announces Business Combination

Hoch Lynelle 🟡 adjusted position in 11.6K shares (5 derivative) of BRISTOL MYERS SQUIBB CO (BMY) at $60.13 Transaction Date: Mar 10, 2026 | Filing ID: 000002

abrdn Global Income Fund, Inc. (FCO) Announces Adjournment of Special Shareholder Meeting Relating to Proposed Reorganization